Early viral brain invasion in iatrogenic human immunodeficiency virus infection
- PMID: 1513462
- DOI: 10.1212/wnl.42.9.1736
Early viral brain invasion in iatrogenic human immunodeficiency virus infection
Abstract
We report a 68-year-old man who received an IV inoculation of WBCs for an indium radionuclide scan containing 600 to 700 tissue culture infectious doses of human immunodeficiency virus type 1 (HIV-1) from an HIV-1-infected individual. The recipient immediately received zidovudine, then was switched to dideoxyinosine and interferon-alpha, but died of hepatorenal syndrome and hepatic encephalopathy 15 days later. HIV-1 cultures were positive from the recipient's blood on day 14 but not days 0, 1, and 8. At autopsy, cultures of parietal lobe isolated HIV-1. HIV-1 nucleic acid was present in several brain areas, but not in several other organs, by two independent laboratories using the polymerase chain reaction. The brain showed mild perivascular cuffing and a mild lymphocytic meningitis, but there was no evidence of glial nodules, giant cells, or white matter abnormalities. HIV-1 pg41 viral antigen was seen by immunoperoxidase staining in rare infiltrating cells within perivascular and subpial spaces. Thus, HIV-1 was isolated from brain 15 days after mistaken HIV-1 inoculation and 1 day after virus was first recovered from blood.
Similar articles
-
HIV-1 infection despite immediate combination antiviral therapy after infusion of contaminated white cells.Am J Med. 1994 Sep;97(3):289-95. doi: 10.1016/0002-9343(94)90012-4. Am J Med. 1994. PMID: 8092178
-
Human microglial cells: characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection.Ann Neurol. 1991 Feb;29(2):152-61. doi: 10.1002/ana.410290207. Ann Neurol. 1991. PMID: 1707249
-
Absence of infectious human immunodeficiency virus type 1 in "natural" eccrine sweat.J Infect Dis. 1992 Jan;165(1):155-8. doi: 10.1093/infdis/165.1.155. J Infect Dis. 1992. PMID: 1345794
-
Zidovudine-interferon-alpha combination therapy in patients with advanced human immunodeficiency virus type 1 infection: biphasic response of p24 antigen and quantitative polymerase chain reaction.J Infect Dis. 1992 May;165(5):793-8. doi: 10.1093/infdis/165.5.793. J Infect Dis. 1992. PMID: 1349031 Clinical Trial.
-
[Lesions of the central nervous system in the early stages of human immunodeficiency virus infection].Rev Neurol (Paris). 1997 Nov;153(11):629-40. Rev Neurol (Paris). 1997. PMID: 9686250 Review. French.
Cited by
-
HIV and COVID-19: two pandemics with significant (but different) central nervous system complications.Free Neuropathol. 2024 Mar 5;5:5-5. doi: 10.17879/freeneuropathology-2024-5343. eCollection 2024 Jan. Free Neuropathol. 2024. PMID: 38469363 Free PMC article.
-
A Canadian Survey of Research on HIV-1 Latency-Where Are We Now and Where Are We Heading?Viruses. 2024 Feb 1;16(2):229. doi: 10.3390/v16020229. Viruses. 2024. PMID: 38400005 Free PMC article. Review.
-
HIV-1 infection of genetically engineered iPSC-derived central nervous system-engrafted microglia in a humanized mouse model.J Virol. 2023 Dec 21;97(12):e0159523. doi: 10.1128/jvi.01595-23. Epub 2023 Nov 30. J Virol. 2023. PMID: 38032195 Free PMC article.
-
The Impact of COVID-19 on People Living with HIV-1 and HIV-1-Associated Neurological Complications.Viruses. 2023 May 5;15(5):1117. doi: 10.3390/v15051117. Viruses. 2023. PMID: 37243203 Free PMC article. Review.
-
Defects in immune response to Toxoplasma gondii are associated with enhanced HIV-1-related neurocognitive impairment in co-infected patients.PLoS One. 2023 May 24;18(5):e0285976. doi: 10.1371/journal.pone.0285976. eCollection 2023. PLoS One. 2023. PMID: 37224128 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical